Abstract | BACKGROUND/AIMS: Controversy exists regarding the diagnosis and treatment of mild congenital hypothyroidism (MCH). We studied the value of (123)I imaging in patients with MCH. METHODS: Retrospective chart review of infants and children <4 years of age who underwent (123)I imaging: group 1 = MCH [ thyroid-stimulating hormone (TSH) <25 µIU/ml, normal free T4/T3], group 2 = severe congenital hypothyroidism (TSH ≥25 µIU/ml), and group 3 = MCH in infancy imaged after treatment withdrawal at age 3 years. Data collected included 4- and 24-hour (123)I uptake, TSH, free T4/total T3 at imaging, age at imaging, and levothyroxine (L-T4) dose at 1 year of. RESULTS: Thirty-six patients underwent (123)I imaging. In group 1 (n = 20, median TSH: 8.49 µIU/ml), 85% had abnormal imaging consistent with dyshormonogenesis. Two patients were referred after 1 year of age. The median age at imaging for the remaining 18 patients was 54 days. Median L-T4 dose at 1 year of age for these 18 patients was 2.8 μg/kg, which is consistent with dyshormonogenesis. Ninety-one percent of group 2 (n = 11, median TSH: 428.03 µIU/ml) had abnormal imaging. The median age at imaging was 13 days. Four patients in group 3 had abnormal (123)I imaging and restarted treatment. CONCLUSION: (123)I imaging is a valuable tool for evaluation, diagnosis, and treatment of MCH.
|
Authors | Evan Graber, Molly O Regelmann, Rachel Annunziato, Josef Machac, Robert Rapaport |
Journal | Hormone research in paediatrics
(Horm Res Paediatr)
Vol. 83
Issue 2
Pg. 94-101
( 2015)
ISSN: 1663-2826 [Electronic] Switzerland |
PMID | 25531155
(Publication Type: Journal Article)
|
Copyright | © 2014 S. Karger AG, Basel. |
Chemical References |
- Iodine Isotopes
- Thyroid Hormones
|
Topics |
- Congenital Hypothyroidism
(blood, diagnostic imaging)
- Female
- Humans
- Infant
- Infant, Newborn
- Iodine Isotopes
(administration & dosage)
- Male
- Radionuclide Imaging
- Retrospective Studies
- Thyroid Dysgenesis
(blood, diagnostic imaging)
- Thyroid Hormones
(blood)
|